Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRTP-101 in Adults With Atrophic Scars
NCT06210919Phase 1Completed
- Sponsor
- CELLinCELLS
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of TRTP-101 in atrophic scar, sponsored by CELLinCELLS. Primary endpoint: Number of Participants with Dose Limiting Toxicity at 4 weeks. Started Dec 2023; status: completed.
02
Drugs
TRTP-101
03
Conditions
atrophic scar
Beyond the preview
Go deeper on NCT06210919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06210919.